Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Parkinson Matters.

Darweesh SKL, Raphael KG, Brundin P, Matthews H, Wyse RK, Chen H, Bloem BR.

J Parkinsons Dis. 2018;8(4):495-498. doi: 10.3233/JPD-181374.

2.

Epidemiology of Parkinson's disease and akinetic syndromes.

Tanner CM, Aston DA.

Curr Opin Neurol. 2000 Aug;13(4):427-30. Review.

PMID:
10970060
3.

Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.

Arai H, Ouchi Y, Toba K, Endo T, Shimokado K, Tsubota K, Matsuo S, Mori H, Yumura W, Yokode M, Rakugi H, Ohshima S.

Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.

PMID:
25656311
4.

Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: a population-based study.

Sleeman KE, Ho YK, Verne J, Glickman M, Silber E, Gao W, Higginson IJ; GUIDE_Care Project.

Palliat Med. 2013 Oct;27(9):840-6. doi: 10.1177/0269216313490436. Epub 2013 Jun 4.

PMID:
23737036
5.

Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Parkinson's Disease Collaborators.

Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.

6.

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM.

JAMA Neurol. 2017 Jul 1;74(7):839-846. doi: 10.1001/jamaneurol.2017.0603.

7.

The Emerging Evidence of the Parkinson Pandemic.

Dorsey ER, Sherer T, Okun MS, Bloem BR.

J Parkinsons Dis. 2018;8(s1):S3-S8. doi: 10.3233/JPD-181474. Review.

8.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

9.

The social impact of Parkinson's disease in Spain: Report by the Spanish Foundation for the Brain.

García-Ramos R, López Valdés E, Ballesteros L, Jesús S, Mir P.

Neurologia. 2016 Jul-Aug;31(6):401-13. doi: 10.1016/j.nrl.2013.04.008. Epub 2013 Jun 28. Review. English, Spanish.

10.

Under-reporting of Parkinson's disease on death certificates: a population-based study (NEDICES).

Benito-León J, Louis ED, Villarejo-Galende A, Romero JP, Bermejo-Pareja F.

J Neurol Sci. 2014 Dec 15;347(1-2):188-92. doi: 10.1016/j.jns.2014.08.048. Epub 2014 Oct 2.

PMID:
25292414
11.

Trajectories of prediagnostic functioning in Parkinson's disease.

Darweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA.

Brain. 2017 Feb;140(2):429-441. doi: 10.1093/brain/aww291. Epub 2017 Jan 12.

PMID:
28082300
12.

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013.

Low V, Ben-Shlomo Y, Coward E, Fletcher S, Walker R, Clarke CE.

Parkinsonism Relat Disord. 2015 May;21(5):449-54. doi: 10.1016/j.parkreldis.2015.01.017. Epub 2015 Feb 17.

PMID:
25737205
13.

[Hospital Mortality in Parkinson's Disease: Retrospective Analysis in a Portuguese Tertiary Centre].

Martins J, Rua A, Vila Chã N.

Acta Med Port. 2016 May;29(5):315-8. Epub 2016 May 31. Portuguese.

15.

Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.

Ghosh B, Mishra A, Sengupta P.

J Indian Med Assoc. 2005 Mar;103(3):146, 148, 150 passim. Review.

PMID:
16173291
16.

[Parkinson's disease and atypical Parkinson syndromes].

Lorenzl S.

MMW Fortschr Med. 2009 Dec 10;151(51-52):39-40. Review. German. No abstract available.

PMID:
20088320
17.

Epidemiology of Parkinson's disease--an overview.

Marttila RJ, Rinne UK.

J Neural Transm. 1981;51(1-2):135-48.

PMID:
7264626
18.

Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.

Clarke CE.

Mov Disord. 1995 May;10(3):250-6. Review.

PMID:
7651439
19.

Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden.

Midlöv P, Bondesson A, Eriksson T, Petersson J, Minthon L, Höglund P.

Eur J Clin Pharmacol. 2002 Feb;57(12):903-10.

PMID:
11936711
20.

Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.

Mylne AQ, Griffiths C, Rooney C, Doyle P.

Eur J Neurol. 2009 Sep;16(9):1010-6. doi: 10.1111/j.1468-1331.2009.02715.x. Epub 2009 Jun 15.

PMID:
19538202

Supplemental Content

Support Center